Home » Topics » BioWorld Science

BioWorld Science
RSS

New CDK and TRK inhibitors identified at Hangzhou Innogate Pharma

Aug. 3, 2021

Bristol Myers Squibb patents CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors

Aug. 3, 2021

Hovione Scientia describes ligand drug conjugates including BET inhibitors

Aug. 3, 2021

Vaxart's IND application for S-only oral tablet COVID-19 vaccine cleared in U.S.

Aug. 3, 2021

First patient dosed in phase II study of ZN-c3 in uterine serous carcinoma

Aug. 3, 2021

U.K. MHRA clears initiation of first-in-human study of HMBD-001 in advanced cancers

Aug. 2, 2021

China NMPA accepts IND for phase I study of CAN-103 for Gaucher's disease

Aug. 2, 2021

Lundbeck opens phase I study of Lu-AG-09222 in headache model

Aug. 2, 2021

Lundbeck studies Lu-AG-06466 in phase I for fibromyalgia

Aug. 2, 2021

Trk-A inhibitor E-2511 restores cholinergic neurons in transgenic models of Alzheimer's disease

Aug. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026